Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas

Istituto Ortopedico Rizzoli16 enrolled

Overview

The study involves blood samples from patients with Ewing's sarcoma to identify circulating biomarkers as a tool for the preclinical validation of innovative therapeutic approaches

Study Type

OBSERVATIONAL

Enrollment

Conditions

Sarcoma, Ewing

Interventions

one blood sampleOTHER

non onco

3 blood samplesOTHER

onco

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion criteria for cancer patients * Male and female patients of any age diagnosed with Ewing sarcoma. * Signed, study-specific informed consent form for the BIOVES study (cancer patients) Inclusion criteria for non-cancer patients * Male and female patients of legal age without a cancer diagnosis. * Signed, study-specific informed consent form for the BIOVES study (non-cancer patients) Exclusion Criteria: Patients who do not meet all inclusion criteria \-

Locations (1)

Istituto ortopedico Rizzoli Laboratorio di Ricerc Oncologica e Genomica funzioanle

Bologna, BO, Italy

RECRUITING

Outcomes

Primary Outcomes

characterisation of circulating biomarkers

search for circulating biomarkers from blood samples taken at three different time points

Time frame: at baseline (time 0); before surgery; after 6 months from surgery

Central Contacts

Katia Scotlandi, MSc

CONTACT

39 051 6366760 katia.scotlandi@ior.it

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.